POSTPARTUM DEPRESSION: OVERVIEW AND TREATMENT OPTIONS ACPE#: 0178-0000-20-103-H04-P

1. What percentage of women are affected by 6. What is brexanonlone’s mechanism of action? postpartum depression? a. Selective inhibitor a. 30% b. Selective serotonin and b. 10-15% c. 15-85% c. Positive gamma-aminobutyric acid-A d. 44% (GABA-A) modulator d. reuptake inhibitor 2. According to the monoamine theory, which neurotransmitters are thought to be imbalanced 7. What medication is FDA approved for postpartum in depression? depression? a. Norepinephrine, Dopamine a. Brexanolone b. Dopamine, Glutamate, b. c. Serotonin, Norepinephrine, Dopamine c. d. GABA, Glutamate d.

3. Which depression scale is recommended by the 8. Which or drug class is not used as frequently Postpartum Major Depression guidelines to due to its adverse event profile? assess and monitor symptoms of postpartum a. Selective serotonin and norepinephrine depression? reuptake inhibitor (SNRIs) a. Hamilton Depression Rating Scale (HAM- b. Selective serotonin reuptake inhibitors D) (SSRIs) b. Edinburgh Postnatal Depression Scale c. Tricyclic (TCAs) (EPDS) d. Bupropion c. Diagnostic and Statistical Manual of Mental Disorders (DSM) 9. What are some risk factors for postpartum d. Patient Health Questionnaire (PHQ) depression? a. Having frequent headaches, strong 4. When assessing the results of EPDS, what score support system indicates the possibility of depression? b. Postpartum depression with a previous a. 10 birth, a weak support system b. 5 c. Excited for childbirth, no family history of c. 21 postpartum depression d. 30 d. Young age, married

5. What is the typical first-line medication treatment 10. What side effect differentiates “baby blues” from for postpartum depression? postpartum depression? a. Selective serotonin reuptake inhibitors a. Mood changes (SSRIs) b. Anxiety b. Tricyclic antidepressants (TCAs) c. Mania c. Electroconvulsive therapy (ECT) d. Suicidal ideation d. Psychotherapy

POSTPARTUM DEPRESSION: OVERVIEW AND TREATMENT OPTIONS ACPE#: 0178-0000-20-103-H04-P

11. What are some types of psychotherapy studied 15. What is the necessary time frame for a diagnosis that can be used for postpartum depression? of postpartum depression? a. Cognitive behavioral therapy, a. Between the first trimester and third interpersonal psychotherapy, non- trimester of pregnancy supportive counseling b. Between the second trimester and first b. Cognitive behavioral therapy, four weeks after delivery psychoeducation, medication therapy c. Between the third trimester and first four c. Interpersonal psychotherapy, weeks after delivery psychodynamic therapy, supportive d. Between the third trimester and first six counseling weeks after delivery d. Cognitive behavior therapy, supportive

counseling, play therapy

12. Which medication class has been the most studied that lead us to believe it is an appropriate, first line option for postpartum depression? a. SNRI

b. TCA

c. Mixed d. SSRI

13. Which medication is matched with their appropriate initiation dose for postpartum depression?

a. 10 mg

b. Sertraline 10 mg c. Bupropion 200 mg d. Nortriptyline 25 mg

14. What is an advantage to electroconvulsive

therapy?

a. This method shows a fast improvement in mild mental health conditions b. This method does not affect the CNS, and therefore patients do not have CNS side effects c. This method shows a fast improvement in

moderate mental health conditions

d. This method shows a fast improvement in severe mental health conditions

POSTPARTUM DEPRESSION: OVERVIEW AND TREATMENT OPTIONS ACPE#: 0178-0000-20-103-H04-P

Participant Information:

AL License # ______CE Assessment Answers Please circle your answers (one answer per question) Name ______1. A B C D Address______2. A B C D 3. A B C D City______State______Zip______4. A B C D 5. A B C D E-mail______6. A B C D 7. A B C D NABP e-Profile # ______8. A B C D MM/DD (month/day of birth) ______9. A B C D 10. A B C D How long did it take you to read the article and complete this test? 11. A B C D 12. A B C D ______hours ______minutes 13. A B C D 14. A B C D

15. A B C D My signature certifies that I have independently taken this CE examination.

Program Evaluation – Must be completed for credit. Please rate the following items on a scale from 1 (poor) to 4 (excellent). The Alabama Pharmacy Association Research and Education Foundation is 1. Overall quality of the article 1 2 3 4 accredited by the Accreditation Council 2. Relevance to pharmacy practice 1 2 3 4 for Pharmacy Education as a provider of continuing pharmacy education. 3. Value of the content 1 2 3 4 Please answer each question, marking whether you agree or disagree. 4. This course met the learning objectives.  Agree  Disagree 5. The article did not promote a particular product or company. Yes  No Impact of the Activity The information presented (check all that apply): 6.  Reinforced my current practice/treatment habits  Will improve my practice/patient outcomes  Provided new ideas or information I expect to use  Adds to my knowledge 7. Will the information presented cause you to make any changes in how you do your job?  Yes  No 8. How committed are you to making these changes? (Not committed) 1 2 3 4 (Very committed). 9. Do you feel future activities on this subject matter are necessary and/or important?  Yes  No Follow-Up As part of our ongoing quality-improvement effort, we would like to be able to contact you in the event we conduct a follow-up survey to assess the impact of our educational interventions on professional practice. Are you willing to participate in such a survey?  Yes  No